La maladie de Parkinson au Canada (serveur d'exploration) - Checkpoint (PubMed)

Index « Mesh.i » - entrée « Receptors, N-Methyl-D-Aspartate »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Receptors, Muscarinic < Receptors, N-Methyl-D-Aspartate < Receptors, Neurotensin  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000883 (2013) Lorraine V. Kalia [Canada] ; Jonathan M. Brotchie ; Susan H. FoxNovel nondopaminergic targets for motor features of Parkinson's disease: review of recent trials.
000946 (2013) Nicolas Morin [Canada] ; Marc Morissette ; Laurent Grégoire ; Baltazar Gomez-Mancilla ; Fabrizio Gasparini ; Thérèse Di PaoloChronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys.
000A29 (2012) Behzad Elahi [Canada] ; Nicolás Phielipp ; Robert ChenN-Methyl-D-Aspartate antagonists in levodopa induced dyskinesia: a meta-analysis.
000D19 (2010) Joseph P. Steiner [États-Unis] ; Kathryn B. Payne ; Christopher Drummond Main ; Sabrina D'Alfonso ; Kirsten X. Jacobsen ; T Philip Hicks ; William A. Staines ; Michael O. PoulterGPI-1046 increases presenilin-1 expression and restores NMDA channel activity.
000E23 (2009) Christina R. Zamzow [Canada] ; Ratna Bose ; Fiona E. ParkinsonN-methyl-D-aspartate-evoked adenosine and inosine release from neurons requires extracellular calcium.
001105 (2006) Marc Morissette [Canada] ; Mehdi Dridi ; Frédéric Calon ; Abdallah Hadj Tahar ; Leonard T. Meltzer ; Paul J. Bédard ; Thérèse Di PaoloPrevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: implication of preproenkephalin.
001106 (2006) Marc Morissette [Canada] ; Mehdi Dridi ; Frédéric Calon ; Abdallah Hadj Tahar ; Leonard T. Meltzer ; Paul J. Bédard ; Thérèse Di PaoloPrevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptors.
001321 (2004) Abdallah Hadj Tahar [Canada] ; Laurent Grégoire ; Aurélie Darré ; Nancy Bélanger ; Leonard Meltzer ; Paul J. BédardEffect of a selective glutamate antagonist on L-dopa-induced dyskinesias in drug-naive parkinsonian monkeys.
001350 (2003) Pierre J. Blanchet [Canada]The fluctuating Parkinsonian patient--clinical and pathophysiological aspects.
001381 (2003) Frédéric Calon [Canada] ; Ali H. Rajput ; Oleh Hornykiewicz ; Paul J. Bédard ; Thérèse Di PaoloLevodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease.
001497 (2001) C. Zhang [Canada] ; J P Steiner ; G S Hamilton ; T P Hicks ; M O PoulterRegeneration of dopaminergic function in 6-hydroxydopamine-lesioned rats by neuroimmunophilin ligand treatment.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Receptors, N-Methyl-D-Aspartate" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Receptors, N-Methyl-D-Aspartate" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Receptors, N-Methyl-D-Aspartate
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022